Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP Chemotherapy With or Without Rituximab for HIV-Associated Non-Hodgkin's Lymphoma
NCT00003595Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 1999
- Primary completion
- Apr 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Started Jan 1999; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003595.